Edwards Lifesciences Reports Second Quarter Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- Wall St slips on rising bond yields; Walmart results weigh
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Deutsche Bank calls Treasury buyback doubling similar to ’operation twist’
Edwards Lifesciences (EW) Tops Q2 EPS by 17c, Offers Guidance
July 23, 2020 4:17 PM EDTEdwards Lifesciences (NYSE: EW) reported Q2 EPS of $0.34, $0.17 better than the analyst estimate of $0.17. Revenue for the quarter came in at $925 million versus the consensus estimate of $797.53 million.
GUIDANCE:
Edwards Lifesciences sees FY2020 EPS of $1.75-$1.95, versus the consensus of $1.63. Edwards Lifesciences sees FY2020 revenue of $4-4.5 billion, versus the consensus of $4.23... More
